Trusted Sources

The best content, commentary and analysis selected from the web on a wide range of financial topics.
An invaluable tool for capturing themes, tracking strategies and developing tactics.
More options



Current search

[×]

Source

: Research Recap
Results 1 - 10 of 261

Results

Skills Mismatch Feeds Jobless Recovery in US

Despite the drop in the U.S. jobless rate to 7.5%, Oxford Analytica warns that the large number of long-term unemployed does not bode well for future economic growth.

Why Have US States Fared Better Than Euro States Since The Great Recession?

Standard & Poor’s examines why the credit quality of US states has fared better than that of Euro member states during the “Great Recession.”

Online Ad Spending Will Surpass National TV in 2015

Online ad spending will surpass national TV in 2015, according to Standard and Poor’s.

More US Tech Companies Pay Dividends, and Increase Them

Technology companies rated by Moody’s are expected to pay out $44.4 billion to shareholders this year, up 35% from last year.And after its recently announced 15% dividend increase, Apple will pay out more than $11 billion in 2013, the most of any company in the US non-financial sector.

Downgrade Risk Remains As Japan’s Credit Quality Hinges On Its Bold Strategy To Reignite Growth

Japan’s latest effort to escape deflation and revive economic growth is a drastic departure from the policies of previous governments, Standard & Poor’s Ratings Services said in a report published today.

Global Oversight of Systemically Important Insurers Will Remain Lighter than for Big Banks

The degree of global oversight of systemically important insurers will remain lighter than for systemically important banks, says Oxford Analytica.

US Housing Recovery Is Taking Hold, But Challenges Remain

After years of tenuous signals, the U.S. housing recovery is now finally on better footing, according to Standard & Poor’s Ratings Services

Key Specialty Drug Developers May Overcome Operating Challenges through Consolidation

Fitch Ratings sees sustained consolidation in the specialty pharmaceutical sector as small market players try to effectively compete with larger market participants and favorably negotiate reimbursement with commercial and government payers.

Date authored

Source

: all » Research Recap

Primary tags

Secondary tags